BassilDT, ZhengB, SuB, et al.Lower incidence of dementia following cancer diagnoses: Evidence from a large cohort and Mendelian randomization study. J Prev Alzheimers Dis, 2024; 11(5):1397–1405; doi: 10.14283/jpad.2024.135
2.
DriverJA, BeiserA, AuR, et al.Inverse association between cancer and Alzheimer’s disease: Results from the Framingham Heart Study. BMJ, 2012; 344:e1442; doi: 10.1136/bmj.e1442
3.
MusiccoM, AdorniF, Di SantoS, et al.Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study. Neurology, 2013; 81(4):322–328; doi: 10.1212/WNL.0b013e31829c5ec1
4.
KangHS, KimJH, LimH, et al.Alzheimer’s Disease and Different Types of Cancer Likelihood: Unveiling Disparities and Potential Protective Effects in a Korean Cohort Study. Cancers (Basel), 2023; 15(18):4615; doi: 10.3390/cancers15184615
5.
HouckAL, SeddighiS, DriverJA. At the crossroads between neurodegeneration and cancer: A review of overlapping biology and its implications. Curr Aging Sci, 2018; 11(2):77–89; doi: 10.2174/1874609811666180223154436
6.
HutchingsC, PhillipsJA, DjamgozMBA. Nerve input to tumours: Pathophysiological consequences of a dynamic relationship. Biochim Biophys Acta Rev Cancer, 2020; 1874(2):188411; doi: 10.1016/j.bbcan.2020.188411
7.
PhillipsJA, HutchingsC, DjamgozMBA. Clinical potential of nerve input to tumors: A bioelectricity perspective. Bioelectricity, 2021; 3(1):14–26; doi: 10.1089/bioe.2020.0051
8.
MancusiR, MonjeM. The neuroscience of cancer. Nature, 2023; 618(7965):467–479; doi: 10.1038/s41586-023-05968-y
9.
FaulknerS, JoblingP, MarchB, et al.Tumor neurobiology and the war of nerves in cancer. Cancer Discov, 2019; 9(6):702–710; doi: 10.1158/2159-8290.CD-18-1398
10.
MagnonC, HallSJ, LinJ, et al.Autonomic nerve development contributes to prostate cancer progression. Science, 2013; 341(6142):1236361; doi: 10.1126/science.1236361
11.
PengT, GuoY, GanZ, et al.Nerve Growth Factor (NGF) Encourages the neuroinvasive potential of pancreatic cancer cells by activating the Warburg effect and promoting tumor derived exosomal miRNA-21 expression. Oxid Med Cell Longev, 2022; 2022:8445093; doi: 10.1155/2022/8445093
12.
LeeWY, SunLM, LinCL, et al.Risk of prostate and bladder cancers in patients with spinal cord injury: A population-based cohort study. Urol Oncol, 2014; 32(1):51.e1-7–51.e7; doi: 10.1016/j.urolonc.2013.07.019
13.
ThayerJF, LaneRD. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol, 2007; 74(2):224–242; doi: 10.1016/j.biopsycho.2005.11.013
14.
DjamgozMBA. Electrical excitability of cancer cells - CELEX model updated. Cancer Metastasis Rev, 2024; 43(4):1579–1591; doi: 10.1007/s10555-024-10195-6
15.
SørensenSA, FengerK, OlsenJH. Significantly lower incidence of cancer among patients with Huntington disease: An apoptotic effect of an expanded polyglutamine tract? Cancer, 1999; 86(7):1342–1346.
16.
DriverJA, LogroscinoG, BuringJE, et al.A prospective cohort study of cancer incidence following the diagnosis of Parkinson’s disease. Cancer Epidemiol Biomarkers Prev, 2007; 16(6):1260–1265; doi: 10.1158/1055-9965.EPI-07-0038
17.
TangC, FuP, LinL, et al.Causal association between Parkinson’s disease and cancer: A bidirectional Mendelian randomization study. Front Aging Neurosci, 2024; 16:1432373; doi: 10.3389/fnagi.2024.1432373
18.
LiuZ, FanT, MoX, et al.Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study. PLoS One, 2024; 19(3):e0298271; doi: 10.1371/journal.pone.0298271
19.
Catalá-LópezF, Tejedor-RomeroL, DriverJA, et al.Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: Study protocol for a systematic review and meta-analysis of randomised and non-randomised studies. Syst Rev, 2024; 13(1):263; doi: 10.1186/s13643-024-02677-z
20.
DjamgozMBA, LevinM. Bioelectricity is the bridge where cancer meets neuroscience. Bioelectricity, 2021; 3(3):159–160; doi: 10.1089/bioe.2021.0024
